


| FiercePharmaAsia—Roche-Innovent deal; Lilly-Junshi COVID pact; Fujifilm, WuXi Biologics expansions |
|
Roche has entered into a nonexclusive licensing deal granting China's Innovent Biologics rights to its bispecific antibodies and cell therapy technologies. Eli Lilly has added Junshi Biosciences' investigational COVID-19 antibody to its pipeline. In two CDMO expansions, Fujifilm is plotting a $928....
Posted: 2020-06-11 22:03:00
|
If you are a broadcaster or Christian program producer you can schedule a 15 min FREE consultation with an EGR specialist to help you evaluate all possible Int'l broadcasting options.
We will call you back at a number and time of your convenience, and will gladly answer any question that you may have on how to broadcast your Christian message worldwide.